AOD9604 5MG

Please be aware all AOD will naturally gel over time, even when mixed with acetic acid. This is a normal characteristic of the product and does not affect its usability. In fact, gelled AOD remains fully functional and can still be used for any research application without issue.

We highly recommend using 1ML acetic acid and 2ML bacteriostatic water. If the product begins to gel simply add more acetic acid. Always reconstitute aod slowly. Using too much agitation can cause AOD to turn solid. To mitigate this issue altogether simply preload all your syringes immediately after reconstitution.

The best way to reconstitute AOD is by using 2ML of Bacteriostatic Water and then slowly add Acetic Acid. Do not splash acetic acid in but rather add a little at a time.

Our AOD is of ultra-high purity, which means it may gel faster than other formulations on the market. This is not a defect but rather a result of its exceptional quality and concentration.

What Reddit Users Say About AOD-9604
Reddit User Experiences With AOD-9604

Many Reddit users report targeted fat loss or body recomposition, particularly in the abdomen.
“AOD is working for me… I believe the AOD is reducing my belly fat. I see a lot of changes especially below the umbilicus.”
r/Peptides_for_Women

Another user said it helped maintain weight loss after stopping it:
“AOD is great if you ask me. I'm taking my first break from it right now and have maintained my loss.”
r/PeptidesForum

Others describe localized fat changes rather than overall weight loss:
“AOD has substantially targeted my stomach… it’s really decreased and thinned out.”
r/Retatrutide

Common positive themes Reddit users mention:

• Belly fat reduction
• Body recomposition rather than scale weight loss
• Works better with fasting + cardio
• Useful stack with GLP-1s

Neutral / Mixed Experiences
A lot of Reddit feedback says results are subtle or slow.
Example:
“I've read mostly positive reviews but a few negatives of it doing nothing.”
r/Tirzeglutide
Some users say it's not strong enough alone:
“It does help with reducing belly fat. I doubt it's going to do much in the weight loss without combining it with a GLP-1.”
r/PeptidesNootropics

Common neutral themes:

• Slow results (weeks or months)
• Better as a support peptide
  Often stacked with:
• retatrutide
• tirzepatide
• semaglutide
• LipoC with L-carnitine
• fat-burning workouts

AOD-9604 – Research Overview
Chemical name: Fragment 177–191 of human growth hormone
Common research name: AOD-9604
Class: Modified GH-fragment peptide
Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Lys
Molecular weight: ~1.8 kDa
Target: GH-fragment–related metabolic pathways (fat-metabolism pathways)

Molecular & Pharmacological Profile
AOD-9604 is a modified fragment of human growth hormone that has been investigated in preclinical studies (animal and cell-based research) for its effects on lipid metabolism (how fat is stored or broken down).
Unlike full-length GH, AOD-9604 does not activate growth hormone receptors (does not behave like GH) and does not increase IGF-1 levels (does not trigger growth-related hormones).
Research in animal and in-vitro models suggests that this fragment may influence:

• Lipolysis (breakdown of stored fat)
• Lipogenesis (creation of new fat)
• Fat oxidation (burning fat for energy)
  All findings refer strictly to laboratory settings, not established effects in humans.

Mechanism of Action (Preclinical)
In experimental systems, AOD-9604 has been shown to:

• Increase the breakdown of stored triglycerides in adipocyte cultures (fat cells releasing stored fat)
• Reduce the formation of new lipids in adipose tissue (less new fat being created)
• Enhance lipolytic enzyme activity (enzymes that help break down fat become more active)
• Act independently of GH receptor signaling (does not activate growth pathways like regular GH)
• This activity appears to be specific to metabolic pathways in fat tissue (primarily affecting fat-related processes rather than other systems).

Preclinical Research: Potential Applications
AOD-9604 has been explored in animal and cell-based research models for:

• Metabolic research (studying how fat is stored, mobilized, or burned)
• Obesity research (understanding fat-mass changes in diet-induced obese rodents)
• Adipocyte biology (how fat cells develop, store energy, or break down lipids)
• Energy-utilization studies (how cells use fuel or shift toward fat oxidation)
  These investigations relate only to preclinical experimentation, not clinical or therapeutic use.

Efficacy Observed in Preclinical Models
Rodent studies:

• AOD-9604 was associated with increased fat oxidation (burning more fat for energy)
• Reduced body fat accumulation (less fat gain) in diet-induced obese rats
  Observed metabolic changes occurred without increases in IGF-1 (no growth-hormone–like effects)
  In vitro (cell-culture) studies:
• Fat cells showed enhanced lipolytic activity (greater breakdown of stored fat)
• Reduced lipid droplet formation (less buildup of new fat inside cells)
• Changes in gene expression related to fat storage vs. fat breakdown (shift toward burning rather than storing)
• These findings are limited to laboratory research, not human outcomes.

Safety Tolerability (Preclinical)
In animal research:

• AOD-9604 did not stimulate IGF-1 (no GH-like growth signaling)
• No increases in linear growth in young rodents (no growth-promoting activity)
• Dose-related metabolic effects were observed (changes in fat metabolism)

Long-term toxicity, human pharmacokinetics, and human tolerability remain undetermined (not studied extensively)
AOD-9604 has not been evaluated or approved as safe for human use.

Regulatory Status Research Disclaimer

• AOD-9604 is an investigational research compound.
• It is not approved by the FDA or any regulatory authority for medical, therapeutic, dietary, or cosmetic use.
• For Research Use Only.
• Not for human consumption. Not for veterinary use.
• Not for diagnostic or therapeutic purposes.
• No medical claims are made or implied.
• Researchers are responsible for compliance with all applicable regulations.

Key References (Preclinical)
Heffernan M. et al. The lipolytic effect of human growth hormone fragment 177–191 in obese Zucker rats. J Endocrinol.
Ng FM. HGH fragment 177–191 increases lipolysis in isolated rat adipocytes. Biochem Mol Biol Int.
Chen C. et al. GH-fragment-specific metabolic activity independent of IGF-1. Peptides.
Heffernan et al. Selective fat-tissue effects of GH-derived fragments. Endocrinology Research.